Gyre Therapeutics Inc (GYRE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -14,762 | -6,613 | -9,966 | -6,998 | -8,529 |
| Depreciation Amortization | 470 | 680 | 974 | 3,149 | 3,391 |
| Accounts receivable | -79 | 1 | -52 | -1,162 | 620 |
| Accounts payable and accrued liabilities | -4,273 | -106 | 11 | N/A | N/A |
| Other Working Capital | -6,260 | -477 | 2,420 | -10,220 | 10,346 |
| Other Operating Activity | 5,786 | 126 | 339 | -49,008 | -89,546 |
| Operating Cash Flow | $-19,118 | $-6,389 | $-6,274 | $-64,239 | $-83,718 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | 38,566 | -56,241 |
| PPE Investments | -272 | 98 | -41 | 1,256 | -1,426 |
| Sale Of Investment | 13,823 | N/A | N/A | N/A | N/A |
| Other Investing Activity | 23,806 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $37,357 | $98 | $-41 | $39,822 | $-57,667 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 1,888 | N/A | N/A | N/A | 2,132 |
| Debt Repayment | -3,020 | N/A | N/A | -1,240 | -1,964 |
| Common Stock Issued | 13 | 25 | N/A | 614 | 82,646 |
| Common Stock Repurchased | -82 | N/A | N/A | N/A | N/A |
| Other Financing Activity | 10,514 | 4,982 | 5,742 | 0 | 0 |
| Financing Cash Flow | $9,313 | $5,007 | $5,742 | $-626 | $82,814 |
| Beginning Cash Position | 1,544 | 2,828 | 3,401 | 107,283 | 165,854 |
| End Cash Position | 29,096 | 1,544 | 2,828 | 82,240 | 107,283 |
| Net Cash Flow | $27,552 | $-1,284 | $-573 | $-25,043 | $-58,571 |
| Free Cash Flow | |||||
| Operating Cash Flow | -19,118 | -6,389 | -6,274 | -64,239 | -83,718 |
| Capital Expenditure | -272 | N/A | -41 | -333 | -1,431 |
| Free Cash Flow | -19,390 | -6,389 | -6,315 | -64,572 | -85,149 |